153 related articles for article (PubMed ID: 28768722)
1. Macrophage migration inhibitory factor enhances
Tynan A; Mawhinney L; Armstrong ME; O'Reilly C; Kennedy S; Caraher E; Jülicher K; O'Dwyer D; Maher L; Schaffer K; Fabre A; McKone EF; Leng L; Bucala R; Bernhagen J; Cooke G; Donnelly SC
FASEB J; 2017 Nov; 31(11):5102-5110. PubMed ID: 28768722
[TBL] [Abstract][Full Text] [Related]
2. Aerosolized drug-loaded nanoparticles targeting migration inhibitory factors inhibit
Doroudian M; O'Neill A; O'Reilly C; Tynan A; Mawhinney L; McElroy A; Webster SS; MacLoughlin R; Volkov Y; E Armstrong M; A O'Toole G; Prina-Mello A; C Donnelly S
Nanomedicine (Lond); 2020 Dec; 15(30):2933-2953. PubMed ID: 33241979
[No Abstract] [Full Text] [Related]
3. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis.
Adamali H; Armstrong ME; McLaughlin AM; Cooke G; McKone E; Costello CM; Gallagher CG; Leng L; Baugh JA; Fingerle-Rowson G; Bucala RJ; McLoughlin P; Donnelly SC
Am J Respir Crit Care Med; 2012 Jul; 186(2):162-9. PubMed ID: 22592805
[TBL] [Abstract][Full Text] [Related]
5. The critical role of macrophage migration inhibitory factor in insulin activity.
Vujicic M; Senerovic L; Nikolic I; Saksida T; Stosic-Grujicic S; Stojanovic I
Cytokine; 2014 Sep; 69(1):39-46. PubMed ID: 25022960
[TBL] [Abstract][Full Text] [Related]
6. A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation.
Fingerle-Rowson G; Kaleswarapu DR; Schlander C; Kabgani N; Brocks T; Reinart N; Busch R; Schütz A; Lue H; Du X; Liu A; Xiong H; Chen Y; Nemajerova A; Hallek M; Bernhagen J; Leng L; Bucala R
Mol Cell Biol; 2009 Apr; 29(7):1922-32. PubMed ID: 19188446
[TBL] [Abstract][Full Text] [Related]
7. Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.
Mawhinney L; Armstrong ME; O' Reilly C; Bucala R; Leng L; Fingerle-Rowson G; Fayne D; Keane MP; Tynan A; Maher L; Cooke G; Lloyd D; Conroy H; Donnelly SC
Mol Med; 2015 Apr; 20(1):729-35. PubMed ID: 25826675
[TBL] [Abstract][Full Text] [Related]
8. The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase.
Rosengren E; Aman P; Thelin S; Hansson C; Ahlfors S; Björk P; Jacobsson L; Rorsman H
FEBS Lett; 1997 Nov; 417(1):85-8. PubMed ID: 9395080
[TBL] [Abstract][Full Text] [Related]
9. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
Price KE; Orazi G; Ruoff KL; Hebert WP; O'Toole GA; Mastoridis P
PLoS One; 2015; 10(10):e0141192. PubMed ID: 26506004
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.
Dickerhof N; Schindler L; Bernhagen J; Kettle AJ; Hampton MB
Free Radic Biol Med; 2015 Dec; 89():498-511. PubMed ID: 26453918
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL
Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
McCaughey G; McKevitt M; Elborn JS; Tunney MM
J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
[TBL] [Abstract][Full Text] [Related]
14. Ketone bodies affect the enzymatic activity of macrophage migration inhibitory factor.
Garai J; Lóránd T; Molnár V
Life Sci; 2005 Aug; 77(12):1375-80. PubMed ID: 15893774
[TBL] [Abstract][Full Text] [Related]
15. Human single-chain variable fragment antibody inhibits macrophage migration inhibitory factor tautomerase activity.
Tarasuk M; Poungpair O; Ungsupravate D; Bangphoomi K; Chaicumpa W; Yenchitsomanus PT
Int J Mol Med; 2014 Mar; 33(3):515-22. PubMed ID: 24424397
[TBL] [Abstract][Full Text] [Related]
16. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
Koeva M; Gutu AD; Hebert W; Wager JD; Yonker LM; O'Toole GA; Ausubel FM; Moskowitz SM; Joseph-McCarthy D
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923873
[TBL] [Abstract][Full Text] [Related]
17. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
Fernández-Olmos A; García-Castillo M; Maiz L; Lamas A; Baquero F; Cantón R
Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530
[TBL] [Abstract][Full Text] [Related]
18. An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity.
El Turk F; Fauvet B; Ouertatani-Sakouhi H; Lugari A; Betzi S; Roche P; Morelli X; Lashuel HA
Bioorg Med Chem; 2010 Jul; 18(14):5425-40. PubMed ID: 20639113
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
Senter PD; Al-Abed Y; Metz CN; Benigni F; Mitchell RA; Chesney J; Han J; Gartner CG; Nelson SD; Todaro GJ; Bucala R
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):144-9. PubMed ID: 11773615
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa.
Pawar V; Komor U; Kasnitz N; Bielecki P; Pils MC; Gocht B; Moter A; Rohde M; Weiss S; Häussler S
Antimicrob Agents Chemother; 2015 Aug; 59(8):4974-81. PubMed ID: 26055372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
